Recent Quotes (30 days)

You have no recent quotes
chg | %

Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
12.60
0.00 (0.00%)
May 22 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 11.68 - 21.50
Open     -
Vol. 0.00
Mkt cap 712.29M
P/E     -
Div/yield     -
EPS -0.81
Shares 56.16M
Beta 0.19
Inst. own     -
Aug 4, 2015
Q2 2015 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 27, 2015
Novadaq Technologies Inc at Craig-Hallum Capital Group Institutional Investor Conference Add to calendar
May 21, 2015
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated)
May 19, 2015
Novadaq Technologies Inc at UBS Global Healthcare Conference
May 14, 2015
Novadaq Technologies Inc at Bank of America Merrill Lynch Health Care Conference
May 13, 2015
Novadaq Technologies Inc Annual Shareholders Meeting
May 4, 2015
Novadaq Technologies Inc at Bloom Burton & Co Healthcare Investor Conference
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Call
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Release
Mar 12, 2015
Novadaq Technologies Inc at Barclays Healthcare Conference - Webcast
  

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -96.53% -52.26%
Operating margin -96.96% -48.75%
EBITD margin - -36.50%
Return on average assets -23.36% -11.90%
Return on average equity -28.23% -14.43%
Employees 56 -
CDP Score - -

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

Description

Novadaq Technologies Inc. primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company’s SPY, SPY Elite, LUNA and PINPOINT Imaging Systems are based upon the Company’s core SPY fluorescence technology. The Company manufactures and markets Heart Laser System [TMR Laser System] for Transmyocardial Revascularization [TMR]. The Company′s SPY Imaging core technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels. PINPOINT provides surgeons with better visualization of important information related to anatomic structures and tissue perfusion during complex minimally invasive procedures.

Officers and directors

Arun Menawat President, Chief Executive Officer, Director
Roger Deck Chief Financial Officer
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Patrice E. Merrin Director
Age: 66
Robert S. White Director
Aaron Davidson Independent Director
Age: 46
Harold O. Koch Jr. Independent Director
Age: 59